TY - JOUR AU - Cooper, C. S. AU - Park, M. AU - Blair, D. G. AU - Tainsky, M. A. AU - Huebner, K. AU - Croce, C. M. PY - 1984 DA - 1984// TI - Molecular cloning of a new transforming gene from a chemically transformed human cell line JO - Nature VL - 311 UR - https://doi.org/10.1038/311029a0 DO - 10.1038/311029a0 ID - Cooper1984 ER - TY - JOUR AU - Nakamura, T. AU - Nawa, K. AU - Ichihara, A. PY - 1984 DA - 1984// TI - Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats JO - Biochem Biophys Res Commun VL - 122 UR - https://doi.org/10.1016/0006-291X(84)91253-1 DO - 10.1016/0006-291X(84)91253-1 ID - Nakamura1984 ER - TY - JOUR AU - Bottaro, D. P. AU - Rubin, J. S. AU - Faletto, D. L. AU - Chan, A. M. AU - Kmiecik, T. E. AU - Vande Woude, G. F. PY - 1991 DA - 1991// TI - Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product JO - Science VL - 251 UR - https://doi.org/10.1126/science.1846706 DO - 10.1126/science.1846706 ID - Bottaro1991 ER - TY - JOUR AU - Schmidt, L. AU - Duh, F. M. AU - Chen, F. AU - Kishida, T. AU - Glenn, G. AU - Choyke, P. PY - 1997 DA - 1997// TI - Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas JO - Nat Genet VL - 16 UR - https://doi.org/10.1038/ng0597-68 DO - 10.1038/ng0597-68 ID - Schmidt1997 ER - TY - JOUR AU - Walker, F. AU - Kermorgant, S. AU - Daraï, E. AU - Madelenat, P. AU - Cremieux, A. C. AU - Hénin, D. PY - 2003 DA - 2003// TI - Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus JO - Clin Cancer Res VL - 9 ID - Walker2003 ER - TY - JOUR AU - Lengyel, E. AU - Prechtel, D. AU - Resau, J. H. AU - Gauger, K. AU - Welk, A. AU - Lindemann, K. PY - 2005 DA - 2005// TI - C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu JO - Int J Cancer VL - 113 UR - https://doi.org/10.1002/ijc.20598 DO - 10.1002/ijc.20598 ID - Lengyel2005 ER - TY - JOUR AU - Kim, C. H. AU - Kim, J. AU - Kahng, H. AU - Choi, E. C. PY - 2007 DA - 2007// TI - Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma JO - Ann Surg Oncol VL - 14 UR - https://doi.org/10.1245/s10434-006-9320-5 DO - 10.1245/s10434-006-9320-5 ID - Kim2007 ER - TY - JOUR AU - Engelman, J. A. AU - Zejnullahu, K. AU - Mitsudomi, T. AU - Song, Y. AU - Hyland, C. AU - Park, J. O. PY - 2007 DA - 2007// TI - MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling JO - Science VL - 316 UR - https://doi.org/10.1126/science.1141478 DO - 10.1126/science.1141478 ID - Engelman2007 ER - TY - JOUR AU - De Oliveira, A. T. AU - Matos, D. AU - Logullo, A. F. AU - DA Silva, S. R. AU - Neto, R. A. AU - Filho, A. L. PY - 2009 DA - 2009// TI - MET Is highly expressed in advanced stages of colorectal cancer and indicates worse prognosis and mortality JO - Anticancer Res VL - 29 ID - De Oliveira2009 ER - TY - JOUR AU - Li, Y. AU - Chen, C. Q. AU - He, Y. L. AU - Cai, S. R. AU - Yang, D. J. AU - He, W. L. PY - 2012 DA - 2012// TI - Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma JO - J Surg Oncol VL - 106 UR - https://doi.org/10.1002/jso.23008 DO - 10.1002/jso.23008 ID - Li2012 ER - TY - STD TI - ClinicalTrials.gov. US National Institutes of Health, Bethesda, MD. http://www.clinicaltrials.gov. Accessed Jun 2014. UR - http://www.clinicaltrials.gov ID - ref11 ER - TY - JOUR AU - Cheang, M. C. AU - Voduc, D. AU - Bajdik, C. AU - Leung, S. AU - McKinney, S. AU - Chia, S. K. PY - 2008 DA - 2008// TI - Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-1658 DO - 10.1158/1078-0432.CCR-07-1658 ID - Cheang2008 ER - TY - JOUR AU - Ho-Yen, C. AU - Bowen, R. L. AU - Jones, J. L. PY - 2012 DA - 2012// TI - Characterization of basal-like breast cancer: an update JO - Diagn Histopathol VL - 18 UR - https://doi.org/10.1016/j.mpdhp.2011.12.002 DO - 10.1016/j.mpdhp.2011.12.002 ID - Ho-Yen2012 ER - TY - JOUR AU - Hanna, J. A. AU - Bordeaux, J. AU - Rimm, D. L. AU - Agarwal, S. PY - 2009 DA - 2009// TI - The function, proteolytic processing, and histopathology of Met in cancer JO - Adv Cancer Res VL - 103 UR - https://doi.org/10.1016/S0065-230X(09)03001-2 DO - 10.1016/S0065-230X(09)03001-2 ID - Hanna2009 ER - TY - JOUR AU - Trusolino, L. AU - Bertotti, A. AU - Comoglio, P. M. PY - 2010 DA - 2010// TI - MET signalling: principles and functions in development, organ regeneration and cancer JO - Nat Rev Mol Cell Biol VL - 11 UR - https://doi.org/10.1038/nrm3012 DO - 10.1038/nrm3012 ID - Trusolino2010 ER - TY - JOUR AU - Goldoni, S. AU - Humphries, A. AU - Nyström, A. AU - Sattar, S. AU - Owens, R. T. AU - McQuillan, D. J. PY - 2009 DA - 2009// TI - Decorin is a novel antagonistic ligand of the Met receptor JO - J Cell Biol VL - 185 UR - https://doi.org/10.1083/jcb.200901129 DO - 10.1083/jcb.200901129 ID - Goldoni2009 ER - TY - JOUR AU - Birchmeier, C. AU - Birchmeier, W. AU - Gherardi, E. AU - Vande Woude, G. F. PY - 2003 DA - 2003// TI - Met, metastasis, motility and more JO - Nat Rev Mol Cell Biol VL - 4 UR - https://doi.org/10.1038/nrm1261 DO - 10.1038/nrm1261 ID - Birchmeier2003 ER - TY - JOUR AU - Gherardi, E. AU - Birchmeier, W. AU - Birchmeier, C. AU - Vande, W. G. PY - 2012 DA - 2012// TI - Targeting MET in cancer: rationale and progress JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3205 DO - 10.1038/nrc3205 ID - Gherardi2012 ER - TY - JOUR AU - Abella, J. V. AU - Peschard, P. AU - Naujokas, M. A. AU - Lin, T. AU - Saucier, C. AU - Urbé, S. PY - 2005 DA - 2005// TI - Met/hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation JO - Mol Cell Biol VL - 25 UR - https://doi.org/10.1128/MCB.25.21.9632-9645.2005 DO - 10.1128/MCB.25.21.9632-9645.2005 ID - Abella2005 ER - TY - JOUR AU - Peschard, P. AU - Park, M. PY - 2007 DA - 2007// TI - From Tpr-Met to Met, tumorigenesis and tubes JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210201 DO - 10.1038/sj.onc.1210201 ID - Peschard2007 ER - TY - JOUR AU - Kermorgant, S. AU - Zicha, D. AU - Parker, P. J. PY - 2004 DA - 2004// TI - PKC controls HGF-dependent c-Met traffic, signalling and cell migration JO - EMBO J VL - 23 UR - https://doi.org/10.1038/sj.emboj.7600396 DO - 10.1038/sj.emboj.7600396 ID - Kermorgant2004 ER - TY - JOUR AU - Kermorgant, S. AU - Parker, P. J. PY - 2008 DA - 2008// TI - Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation JO - J Cell Biol VL - 182 UR - https://doi.org/10.1083/jcb.200806076 DO - 10.1083/jcb.200806076 ID - Kermorgant2008 ER - TY - JOUR AU - Barrow-McGee, R. AU - Kermorgant, S. PY - 2014 DA - 2014// TI - Met endosomal signalling: in the right place, at the right time JO - Int J Biochem Cell Biol VL - 49 UR - https://doi.org/10.1016/j.biocel.2014.01.009 DO - 10.1016/j.biocel.2014.01.009 ID - Barrow-McGee2014 ER - TY - JOUR AU - Andermarcher, E. AU - Surani, M. A. AU - Gherardi, E. PY - 1996 DA - 1996// TI - Co-expression of the HGF/SF and c-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis JO - Dev Genet VL - 18 UR - https://doi.org/3.0.CO;2-8 DO - 3.0.CO;2-8 ID - Andermarcher1996 ER - TY - JOUR AU - Niranjan, B. AU - Buluwela, L. AU - Yant, J. AU - Perusinghe, N. AU - Atherton, A. AU - Phippard, D. PY - 1995 DA - 1995// TI - HGF/SF: a potent cytokine for mammary growth, morphogenesis and development JO - Development VL - 121 ID - Niranjan1995 ER - TY - JOUR AU - Yant, J. AU - Buluwela, L. AU - Niranjan, B. AU - Gusterson, B. AU - Kamalati, T. PY - 1998 DA - 1998// TI - In vivo effects of hepatocyte growth factor/scatter factor on mouse mammary gland development JO - Exp Cell Res VL - 241 UR - https://doi.org/10.1006/excr.1998.4028 DO - 10.1006/excr.1998.4028 ID - Yant1998 ER - TY - JOUR AU - Gastaldi, S. AU - Sassi, F. AU - Accornero, P. AU - Torti, D. AU - Galimi, F. AU - Migliardi, G. PY - 2013 DA - 2013// TI - Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer JO - Oncogene VL - 32 UR - https://doi.org/10.1038/onc.2012.154 DO - 10.1038/onc.2012.154 ID - Gastaldi2013 ER - TY - JOUR AU - Sierra, J. R. AU - Tsao, M. S. PY - 2011 DA - 2011// TI - c-MET as a potential therapeutic target and biomarker in cancer JO - Ther Adv Med Oncol VL - 3 UR - https://doi.org/10.1177/1758834011422557 DO - 10.1177/1758834011422557 ID - Sierra2011 ER - TY - JOUR AU - Stella, G. M. AU - Benvenuti, S. AU - Gramaglia, D. AU - Scarpa, A. AU - Tomezzoli, A. AU - Cassoni, P. PY - 2011 DA - 2011// TI - MET mutations in cancers of unknown primary origin (CUPs) JO - Hum Mutat VL - 32 UR - https://doi.org/10.1002/humu.21374 DO - 10.1002/humu.21374 ID - Stella2011 ER - TY - JOUR AU - Bièche, I. AU - Champème, M. H. AU - Lidereau, R. PY - 1999 DA - 1999// TI - Infrequent mutations of the MET gene in sporadic breast tumours JO - Int J Cancer VL - 82 UR - https://doi.org/3.0.CO;2-N DO - 3.0.CO;2-N ID - Bièche1999 ER - TY - JOUR AU - Ma, J. AU - DeFrances, M. C. AU - Zou, C. AU - Johnson, C. AU - Ferrell, R. AU - Zarnegar, R. PY - 2009 DA - 2009// TI - Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer JO - J Clin Invest VL - 119 UR - https://doi.org/10.1172/JCI36640 DO - 10.1172/JCI36640 ID - Ma2009 ER - TY - JOUR AU - Carracedo, A. AU - Egervari, K. AU - Salido, M. AU - Rojo, F. AU - Corominas, J. M. AU - Arumi, M. PY - 2009 DA - 2009// TI - FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors JO - Breast Cancer Res VL - 11 UR - https://doi.org/10.1186/bcr2239 DO - 10.1186/bcr2239 ID - Carracedo2009 ER - TY - JOUR AU - Gonzalez-Angulo, A. M. AU - Chen, H. AU - Karuturi, M. S. AU - Chavez-MacGregor, M. AU - Tsavachidis, S. AU - Meric-Bernstam, F. PY - 2013 DA - 2013// TI - Frequency of mesenchymal–epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer JO - Cancer VL - 119 UR - https://doi.org/10.1002/cncr.27608 DO - 10.1002/cncr.27608 ID - Gonzalez-Angulo2013 ER - TY - JOUR AU - Minuti, G. AU - Cappuzzo, F. AU - Duchnowska, R. AU - Jassem, J. AU - Fabi, A. AU - O’Brien, T. PY - 2012 DA - 2012// TI - Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer JO - Br J Cancer VL - 107 UR - https://doi.org/10.1038/bjc.2012.335 DO - 10.1038/bjc.2012.335 ID - Minuti2012 ER - TY - JOUR AU - Tuck, A. B. AU - Park, M. AU - Sterns, E. E. AU - Boag, A. AU - Elliott, B. E. PY - 1996 DA - 1996// TI - Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma JO - Am J Pathol VL - 148 ID - Tuck1996 ER - TY - JOUR AU - Jin, L. AU - Fuchs, A. AU - Schnitt, S. J. AU - Yao, Y. AU - Joseph, A. AU - Lamszus, K. PY - 1997 DA - 1997// TI - Expression of scatter factor and c-met receptor in benign and malignant breast tissue JO - Cancer VL - 79 UR - https://doi.org/3.0.CO;2-# DO - 3.0.CO;2-# ID - Jin1997 ER - TY - JOUR AU - Edakuni, G. AU - Sasatomi, E. AU - Satoh, T. AU - Tokunaga, O. AU - Miyazaki, K. PY - 2001 DA - 2001// TI - Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma JO - Pathol Int VL - 51 UR - https://doi.org/10.1046/j.1440-1827.2001.01182.x DO - 10.1046/j.1440-1827.2001.01182.x ID - Edakuni2001 ER - TY - JOUR AU - Kang, J. Y. AU - Dolled-Filhart, M. AU - Ocal, I. T. AU - Singh, B. AU - Lin, C. Y. AU - Dickson, R. B. PY - 2003 DA - 2003// TI - Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer JO - Cancer Res VL - 63 ID - Kang2003 ER - TY - JOUR AU - Baker, A. F. AU - Dragovich, T. AU - Ihle, N. T. AU - Williams, R. AU - Fenoglio-Preiser, C. AU - Powis, G. PY - 2005 DA - 2005// TI - Stability of phosphoprotein as a biological marker of tumor signaling JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0422 DO - 10.1158/1078-0432.CCR-05-0422 ID - Baker2005 ER - TY - JOUR AU - Dua, R. AU - Zhang, J. AU - Parry, G. AU - Penuel, E. PY - 2011 DA - 2011// TI - Detection of hepatocyte growth factor (HGF) ligand-c-MET receptor activation in formalin-fixed paraffin embedded specimens by a novel proximity assay JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0015932 DO - 10.1371/journal.pone.0015932 ID - Dua2011 ER - TY - JOUR AU - Jarvius, M. AU - Paulsson, J. AU - Weibrecht, I. AU - Leuchowius, K. J. AU - Andersson, A. C. AU - Wählby, C. PY - 2007 DA - 2007// TI - In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method JO - Mol Cell Proteomics VL - 6 UR - https://doi.org/10.1074/mcp.M700166-MCP200 DO - 10.1074/mcp.M700166-MCP200 ID - Jarvius2007 ER - TY - JOUR AU - Blokzijl, A. AU - Friedman, M. AU - Pontén, F. AU - Landegren, U. PY - 2010 DA - 2010// TI - Profiling protein expression and interactions: proximity ligation as a tool for personalized medicine JO - J Intern Med VL - 268 UR - https://doi.org/10.1111/j.1365-2796.2010.02256.x DO - 10.1111/j.1365-2796.2010.02256.x ID - Blokzijl2010 ER - TY - JOUR AU - Hochgräfe, F. AU - Zhang, L. AU - O’Toole, S. A. AU - Browne, B. C. AU - Pinese, M. AU - Porta Cubas, A. PY - 2010 DA - 2010// TI - Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-0911 DO - 10.1158/0008-5472.CAN-10-0911 ID - Hochgräfe2010 ER - TY - JOUR AU - Raghav, K. P. AU - Wang, W. AU - Liu, S. AU - Chavez-MacGregor, M. AU - Meng, X. AU - Hortobagyi, G. N. PY - 2012 DA - 2012// TI - cMET and phospho-cMET protein levels in breast cancers and survival outcomes JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2830 DO - 10.1158/1078-0432.CCR-11-2830 ID - Raghav2012 ER - TY - JOUR AU - Ghoussoub, R. A. AU - Dillon, D. A. AU - D’Aquila, T. AU - Rimm, E. B. AU - Fearon, E. R. AU - Rimm, D. L. PY - 1998 DA - 1998// TI - Expression of c-met is a strong independent prognostic factor in breast carcinoma JO - Cancer VL - 82 UR - https://doi.org/3.0.CO;2-7 DO - 3.0.CO;2-7 ID - Ghoussoub1998 ER - TY - JOUR AU - Camp, R. L. AU - Rimm, E. B. AU - Rimm, D. L. PY - 1999 DA - 1999// TI - Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma JO - Cancer VL - 86 UR - https://doi.org/3.0.CO;2-2 DO - 3.0.CO;2-2 ID - Camp1999 ER - TY - JOUR AU - Tolgay Ocal, I. AU - Dolled-Filhart, M. AU - D’Aquila, T. G. AU - Camp, R. L. AU - Rimm, D. L. PY - 2003 DA - 2003// TI - Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors JO - Cancer VL - 97 UR - https://doi.org/10.1002/cncr.11335 DO - 10.1002/cncr.11335 ID - Tolgay Ocal2003 ER - TY - JOUR AU - Chen, H. H. AU - Su, W. C. AU - Lin, P. W. AU - Guo, H. R. AU - Lee, W. Y. PY - 2007 DA - 2007// TI - Hypoxia-inducible factor-1alpha correlates with MET and metastasis in node-negative breast cancer JO - Breast Cancer Res Treat VL - 103 UR - https://doi.org/10.1007/s10549-006-9360-3 DO - 10.1007/s10549-006-9360-3 ID - Chen2007 ER - TY - JOUR AU - Zagouri, F. AU - Bago-Horvath, Z. AU - Rössler, F. AU - Brandstetter, A. AU - Bartsch, R. AU - Papadimitriou, C. A. PY - 2013 DA - 2013// TI - High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2013.31 DO - 10.1038/bjc.2013.31 ID - Zagouri2013 ER - TY - JOUR AU - Ho-Yen, C. M. AU - Green, A. R. AU - Rakha, E. A. AU - Brentnall, A. R. AU - Ellis, I. O. AU - Kermorgant, S. PY - 2014 DA - 2014// TI - C-Met in invasive breast cancer: is there a relationship with the basal-like subtype? JO - Cancer VL - 120 UR - https://doi.org/10.1002/cncr.28386 DO - 10.1002/cncr.28386 ID - Ho-Yen2014 ER - TY - JOUR AU - Kim, Y. J. AU - Choi, J. S. AU - Seo, J. AU - Song, J. Y. AU - Lee, S. E. AU - Kwon, M. J. PY - 2014 DA - 2014// TI - MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer JO - Int J Cancer VL - 134 UR - https://doi.org/10.1002/ijc.28566 DO - 10.1002/ijc.28566 ID - Kim2014 ER - TY - JOUR AU - Pozner-Moulis, S. AU - Cregger, M. AU - Camp, R. L. AU - Rimm, D. L. PY - 2007 DA - 2007// TI - Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model JO - Lab Invest VL - 87 UR - https://doi.org/10.1038/labinvest.3700515 DO - 10.1038/labinvest.3700515 ID - Pozner-Moulis2007 ER - TY - JOUR AU - Nakopoulou, L. AU - Gakiopoulou, H. AU - Keramopoulos, A. AU - Giannopoulou, I. AU - Athanassiadou, P. AU - Mavrommatis, J. PY - 2000 DA - 2000// TI - c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma JO - Histopathology VL - 36 UR - https://doi.org/10.1046/j.1365-2559.2000.00847.x DO - 10.1046/j.1365-2559.2000.00847.x ID - Nakopoulou2000 ER - TY - CHAP AU - Harris, G. AU - Pinder, S. E. AU - O’Malley, F. P. ED - O’Malley, F. P. ED - Pinder, S. E. PY - 2006 DA - 2006// TI - Invasive carcinoma: special types BT - Breast pathology PB - Elsevier CY - Philadelphia UR - https://doi.org/10.1016/B978-0-443-06680-1.50025-9 DO - 10.1016/B978-0-443-06680-1.50025-9 ID - Harris2006 ER - TY - JOUR AU - Charafe-Jauffret, E. AU - Ginestier, C. AU - Monville, F. AU - Finetti, P. AU - Adélaïde, J. AU - Cervera, N. PY - 2006 DA - 2006// TI - Gene expression profiling of breast cell lines identifies potential new basal markers JO - Oncogene VL - 25 UR - https://doi.org/10.1038/sj.onc.1209254 DO - 10.1038/sj.onc.1209254 ID - Charafe-Jauffret2006 ER - TY - JOUR AU - Lehmann, B. D. AU - Bauer, J. A. AU - Chen, X. AU - Sanders, M. E. AU - Chakravarthy, A. B. AU - Shyr, Y. PY - 2011 DA - 2011// TI - Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI45014 DO - 10.1172/JCI45014 ID - Lehmann2011 ER - TY - JOUR AU - Elston, C. W. AU - Ellis, I. O. PY - 1991 DA - 1991// TI - Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up JO - Histopathology VL - 19 UR - https://doi.org/10.1111/j.1365-2559.1991.tb00229.x DO - 10.1111/j.1365-2559.1991.tb00229.x ID - Elston1991 ER - TY - JOUR AU - Tsarfaty, I. AU - Resau, J. H. AU - Rulong, S. AU - Keydar, I. AU - Faletto, D. L. AU - Vande Woude, G. F. PY - 1992 DA - 1992// TI - The met proto-oncogene receptor and lumen formation JO - Science VL - 257 UR - https://doi.org/10.1126/science.1387731 DO - 10.1126/science.1387731 ID - Tsarfaty1992 ER - TY - JOUR AU - Hiscox, S. AU - Parr, C. AU - Nakamura, T. AU - Matsumoto, K. AU - Mansel, R. E. AU - Jiang, W. G. PY - 2000 DA - 2000// TI - Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4 JO - Breast Cancer Res Treat VL - 59 UR - https://doi.org/10.1023/A:1006348317841 DO - 10.1023/A:1006348317841 ID - Hiscox2000 ER - TY - JOUR AU - Jedeszko, C. AU - Victor, B. C. AU - Podgorski, I. AU - Sloane, B. F. PY - 2009 DA - 2009// TI - Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-1043 DO - 10.1158/0008-5472.CAN-09-1043 ID - Jedeszko2009 ER - TY - JOUR AU - Hung, C. M. AU - Kuo, D. H. AU - Chou, C. H. AU - Su, Y. C. AU - Ho, C. T. AU - Way, T. D. PY - 2011 DA - 2011// TI - Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial–mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells JO - J Agric Food Chem VL - 59 UR - https://doi.org/10.1021/jf2021489 DO - 10.1021/jf2021489 ID - Hung2011 ER - TY - JOUR AU - Ayoub, N. M. AU - Akl, M. R. AU - Sylvester, P. W. PY - 2013 DA - 2013// TI - Combined γ-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration JO - Cell Prolif VL - 46 ID - Ayoub2013 ER - TY - JOUR AU - Eterno, V. AU - Zambelli, A. AU - Pavesi, L. AU - Villani, L. AU - Zanini, V. AU - Petrolo, G. PY - 2014 DA - 2014// TI - Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.1359 DO - 10.18632/oncotarget.1359 ID - Eterno2014 ER - TY - JOUR AU - Date, K. AU - Matsumoto, K. AU - Shimura, H. AU - Tanaka, M. AU - Nakamura, T. PY - 1997 DA - 1997// TI - HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor JO - FEBS Lett VL - 420 UR - https://doi.org/10.1016/S0014-5793(97)01475-0 DO - 10.1016/S0014-5793(97)01475-0 ID - Date1997 ER - TY - JOUR AU - Hiscox, S. AU - Jiang, W. G. PY - 1999 DA - 1999// TI - Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells JO - Biochem Biophys Res Commun VL - 261 UR - https://doi.org/10.1006/bbrc.1999.1002 DO - 10.1006/bbrc.1999.1002 ID - Hiscox1999 ER - TY - JOUR AU - Beviglia, L. AU - Kramer, R. H. PY - 1999 DA - 1999// TI - HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cells JO - Int J Cancer VL - 83 UR - https://doi.org/3.0.CO;2-D DO - 3.0.CO;2-D ID - Beviglia1999 ER - TY - JOUR AU - Reshetnikova, G. PY - 2007 DA - 2007// TI - Met receptor subcellular localization depends on E-cadherin function JO - ScientificWorldJournal VL - 7 UR - https://doi.org/10.1100/tsw.2007.312 DO - 10.1100/tsw.2007.312 ID - Reshetnikova2007 ER - TY - JOUR AU - Thiery, J. P. PY - 2002 DA - 2002// TI - Epithelial–mesenchymal transitions in tumour progression JO - Nat Rev Cancer VL - 2 UR - https://doi.org/10.1038/nrc822 DO - 10.1038/nrc822 ID - Thiery2002 ER - TY - JOUR AU - Rodriguez, F. J. AU - Lewis-Tuffin, L. J. AU - Anastasiadis, P. Z. PY - 1826 DA - 1826// TI - E-cadherin’s dark side: possible role in tumor progression JO - Biochim Biophys Acta VL - 2012 ID - Rodriguez1826 ER - TY - JOUR AU - Matteucci, E. AU - Ridolfi, E. AU - Desiderio, M. A. PY - 2006 DA - 2006// TI - Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells JO - Cell Mol Life Sci VL - 63 UR - https://doi.org/10.1007/s00018-006-6137-0 DO - 10.1007/s00018-006-6137-0 ID - Matteucci2006 ER - TY - JOUR AU - Wang, X. AU - DeFrances, M. C. AU - Dai, Y. AU - Pediaditakis, P. AU - Johnson, C. AU - Bell, A. PY - 2002 DA - 2002// TI - A mechanism of cell survival: sequestration of Fas by the HGF receptor Met JO - Mol Cell VL - 9 UR - https://doi.org/10.1016/S1097-2765(02)00439-2 DO - 10.1016/S1097-2765(02)00439-2 ID - Wang2002 ER - TY - JOUR AU - Shen, K. AU - Novak, R. F. PY - 1997 DA - 1997// TI - Fas-signaling and effects on receptor tyrosine kinase signal transduction in human breast epithelial cells JO - Biochem Biophys Res Commun VL - 230 UR - https://doi.org/10.1006/bbrc.1996.5896 DO - 10.1006/bbrc.1996.5896 ID - Shen1997 ER - TY - JOUR AU - Fan, S. AU - Wang, J. A. AU - Yuan, R. Q. AU - Rockwell, S. AU - Andres, J. AU - Zlatapolskiy, A. PY - 1998 DA - 1998// TI - Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents JO - Oncogene VL - 17 UR - https://doi.org/10.1038/sj.onc.1201943 DO - 10.1038/sj.onc.1201943 ID - Fan1998 ER - TY - JOUR AU - Gao, M. AU - Fan, S. AU - Goldberg, I. D. AU - Laterra, J. AU - Kitsis, R. N. AU - Rosen, E. M. PY - 2001 DA - 2001// TI - Hepatocyte growth factor/scatter factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M106791200 DO - 10.1074/jbc.M106791200 ID - Gao2001 ER - TY - JOUR AU - Lai, A. Z. AU - Abella, J. V. AU - Park, M. PY - 2009 DA - 2009// TI - Crosstalk in Met receptor oncogenesis JO - Trends Cell Biol VL - 19 UR - https://doi.org/10.1016/j.tcb.2009.07.002 DO - 10.1016/j.tcb.2009.07.002 ID - Lai2009 ER - TY - JOUR AU - Bonine-Summers, A. R. AU - Aakre, M. E. AU - Brown, K. A. AU - Arteaga, C. L. AU - Pietenpol, J. A. AU - Moses, H. L. PY - 2007 DA - 2007// TI - Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells JO - Cancer Biol Ther VL - 6 UR - https://doi.org/10.4161/cbt.6.4.3851 DO - 10.4161/cbt.6.4.3851 ID - Bonine-Summers2007 ER - TY - JOUR AU - Paulson, A. K. AU - Linklater, E. S. AU - Berghuis, B. D. AU - App, C. A. AU - Oostendorp, L. D. AU - Paulson, J. E. PY - 2013 DA - 2013// TI - MET and ERBB2 are coexpressed in ERBB2+ breast cancer and contribute to innate resistance JO - Mol Cancer Res VL - 11 UR - https://doi.org/10.1158/1541-7786.MCR-13-0042 DO - 10.1158/1541-7786.MCR-13-0042 ID - Paulson2013 ER - TY - JOUR AU - Mueller, K. L. AU - Hunter, L. A. AU - Ethier, S. P. AU - Boerner, J. L. PY - 2008 DA - 2008// TI - Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0132 DO - 10.1158/0008-5472.CAN-08-0132 ID - Mueller2008 ER - TY - JOUR AU - Shattuck, D. L. AU - Miller, J. K. AU - Carraway, K. L. AU - Sweeney, C. PY - 2008 DA - 2008// TI - Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-5962 DO - 10.1158/0008-5472.CAN-07-5962 ID - Shattuck2008 ER - TY - JOUR AU - Gallego, M. I. AU - Bierie, B. AU - Hennighausen, L. PY - 2003 DA - 2003// TI - Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1207063 DO - 10.1038/sj.onc.1207063 ID - Gallego2003 ER - TY - JOUR AU - Ponzo, M. G. AU - Lesurf, R. AU - Petkiewicz, S. AU - O’Malley, F. P. AU - Pinnaduwage, D. AU - Andrulis, I. L. PY - 2009 DA - 2009// TI - Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0810402106 DO - 10.1073/pnas.0810402106 ID - Ponzo2009 ER - TY - JOUR AU - Graveel, C. R. AU - DeGroot, J. D. AU - Su, Y. AU - Koeman, J. AU - Dykema, K. AU - Leung, S. PY - 2009 DA - 2009// TI - Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0810403106 DO - 10.1073/pnas.0810403106 ID - Graveel2009 ER - TY - JOUR AU - Knight, J. F. AU - Lesurf, R. AU - Zhao, H. AU - Pinnaduwage, D. AU - Davis, R. R. AU - Saleh, S. M. PY - 2013 DA - 2013// TI - Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1210353110 DO - 10.1073/pnas.1210353110 ID - Knight2013 ER - TY - JOUR AU - Fulford, L. G. AU - Easton, D. F. AU - Reis-Filho, J. S. AU - Sofronis, A. AU - Gillett, C. E. AU - Lakhani, S. R. PY - 2006 DA - 2006// TI - Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast JO - Histopathology VL - 49 UR - https://doi.org/10.1111/j.1365-2559.2006.02453.x DO - 10.1111/j.1365-2559.2006.02453.x ID - Fulford2006 ER - TY - JOUR AU - Livasy, C. A. AU - Karaca, G. AU - Nanda, R. AU - Tretiakova, M. S. AU - Olopade, O. I. AU - Moore, D. T. PY - 2006 DA - 2006// TI - Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma JO - Mod Pathol VL - 19 UR - https://doi.org/10.1038/modpathol.3800528 DO - 10.1038/modpathol.3800528 ID - Livasy2006 ER - TY - JOUR AU - Herschkowitz, J. I. AU - Simin, K. AU - Weigman, V. J. AU - Mikaelian, I. AU - Usary, J. AU - Hu, Z. PY - 2007 DA - 2007// TI - Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors JO - Genome Biol VL - 8 UR - https://doi.org/10.1186/gb-2007-8-5-r76 DO - 10.1186/gb-2007-8-5-r76 ID - Herschkowitz2007 ER - TY - JOUR AU - Gentile, A. AU - Trusolino, L. AU - Comoglio, P. M. PY - 2008 DA - 2008// TI - The Met tyrosine kinase receptor in development and cancer JO - Cancer Metastasis Rev VL - 27 UR - https://doi.org/10.1007/s10555-007-9107-6 DO - 10.1007/s10555-007-9107-6 ID - Gentile2008 ER - TY - JOUR AU - Yano, S. AU - Nakagawa, T. PY - 2014 DA - 2014// TI - The current state of molecularly targeted drugs targeting HGF/Met JO - Jpn J Clin Oncol VL - 44 UR - https://doi.org/10.1093/jjco/hyt188 DO - 10.1093/jjco/hyt188 ID - Yano2014 ER - TY - JOUR AU - Cecchi, F. AU - Rabe, D. C. AU - Bottaro, D. P. PY - 2010 DA - 2010// TI - Targeting the HGF/Met signalling pathway in cancer JO - Eur J Cancer VL - 46 UR - https://doi.org/10.1016/j.ejca.2010.02.028 DO - 10.1016/j.ejca.2010.02.028 ID - Cecchi2010 ER - TY - JOUR AU - Yap, T. A. AU - Olmos, D. AU - Brunetto, A. T. AU - Tunariu, N. AU - Barriuso, J. AU - Riisnaes, R. PY - 2011 DA - 2011// TI - Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.31.0367 DO - 10.1200/JCO.2010.31.0367 ID - Yap2011 ER - TY - JOUR AU - Yakes, F. M. AU - Chen, J. AU - Tan, J. AU - Yamaguchi, K. AU - Shi, Y. AU - Yu, P. PY - 2011 DA - 2011// TI - Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth JO - Mol Cancer Ther VL - 10 UR - https://doi.org/10.1158/1535-7163.MCT-11-0264 DO - 10.1158/1535-7163.MCT-11-0264 ID - Yakes2011 ER - TY - JOUR AU - Qian, F. AU - Engst, S. AU - Yamaguchi, K. AU - Yu, P. AU - Won, K. A. AU - Mock, L. PY - 2009 DA - 2009// TI - Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-4889 DO - 10.1158/0008-5472.CAN-08-4889 ID - Qian2009 ER - TY - JOUR AU - Eder, J. P. AU - Shapiro, G. I. AU - Appleman, L. J. AU - Zhu, A. X. AU - Miles, D. AU - Keer, H. PY - 2010 DA - 2010// TI - A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2 JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-0574 DO - 10.1158/1078-0432.CCR-10-0574 ID - Eder2010 ER -